These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36839586)

  • 1. Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with
    Soyer TG; Ramos FF; Pereira IAG; Lage DP; Bandeira RS; de Jesus MM; Costa GP; Machado AS; Freitas CS; Vale DL; Martins VT; Galdino AS; Chávez-Fumagalli MA; Menezes-Souza D; Duarte MC; Roatt BM; Coelho EAF; Tavares GSV
    Pathogens; 2023 Feb; 12(2):. PubMed ID: 36839586
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy Combining Mimotopes Selected by Phage Display Plus Amphotericin B Is Effective for Treatment Against Visceral Leishmaniasis.
    Soyer TG; Bandeira Câmara RS; Pereira IAG; Ramos FF; de Jesus MM; Ludolf F; de Paula Costa G; Lage DP; de Freitas CS; Vale DL; Pimenta BL; Martins VT; Galdino AS; Chávez-Fumagalli MA; Roatt BM; de Sousa Vieira Tavares G; Coelho EAF
    Parasite Immunol; 2024 May; 46(5):e13037. PubMed ID: 38720446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis.
    Vale DL; Freitas CS; Martins VT; Moreira GJL; Machado AS; Ramos FF; Pereira IAG; Bandeira RS; de Jesus MM; Tavares GSV; Ludolf F; Chávez-Fumagalli MA; Galdino AS; Fujiwara RT; Bueno LL; Roatt BM; Christodoulides M; Coelho EAF; Lage DP
    Biology (Basel); 2023 Jun; 12(6):. PubMed ID: 37372136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis.
    Freitas CS; Lage DP; Machado AS; Vale DL; Martins VT; Cardoso JMO; Oliveira-da-Silva JA; Reis TAR; Tavares GSV; Ramos FF; Ludolf F; Pereira IAG; Bandeira RS; Fujiwara RT; Bueno LL; Roatt BM; Chávez-Fumagalli MA; Coelho EAF
    Cytokine; 2023 Apr; 164():156143. PubMed ID: 36774730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
    Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA
    Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-through identification of T cell-specific phage-exposed mimotopes using PBMCs from tegumentary leishmaniasis patients and their use as vaccine candidates against Leishmania amazonensis infection.
    Carvalho GB; Costa LE; Lage DP; Ramos FF; Santos TTO; Ribeiro PAF; Dias DS; Salles BCS; Lima MP; Carvalho LM; Dias ACS; Alves PT; Franklin ML; Silva RAM; Duarte MC; Menezes-Souza D; Roatt BM; Chávez-Fumagalli MA; Goulart LR; Teixeira AL; Coelho EAF
    Parasitology; 2019 Mar; 146(3):322-332. PubMed ID: 30198459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis.
    Ribeiro TG; Franca JR; Fuscaldi LL; Santos ML; Duarte MC; Lage PS; Martins VT; Costa LE; Fernandes SO; Cardoso VN; Castilho RO; Soto M; Tavares CA; Faraco AA; Coelho EA; Chávez-Fumagalli MA
    Int J Nanomedicine; 2014; 9():5341-53. PubMed ID: 25429219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis.
    Sousa JKT; Antinarelli LMR; Mendonça DVC; Lage DP; Tavares GSV; Dias DS; Ribeiro PAF; Ludolf F; Coelho VTS; Oliveira-da-Silva JA; Perin L; Oliveira BA; Alvarenga DF; Chávez-Fumagalli MA; Brandão GC; Nobre V; Pereira GR; Coimbra ES; Coelho EAF
    Parasitol Int; 2019 Dec; 73():101966. PubMed ID: 31362122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice.
    Lage DP; Martins VT; Vale DL; Freitas CS; Pimenta BL; Moreira GJL; Ramos FF; Pereira IAG; Bandeira RS; de Jesus MM; Ludolf F; Tavares GSV; Chávez-Fumagalli MA; Roatt BM; Christodoulides M; Coelho EAF
    Acta Trop; 2023 Oct; 246():106986. PubMed ID: 37453579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium indicus pranii (Mw) re-establishes host protective immune response in Leishmania donovani infected macrophages: critical role of IL-12.
    Adhikari A; Gupta G; Majumder S; Banerjee S; Bhattacharjee S; Bhattacharya P; Kumari S; Haldar S; Majumdar SB; Saha B; Majumdar S
    PLoS One; 2012; 7(7):e40265. PubMed ID: 22792256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system.
    Ribeiro TG; Chávez-Fumagalli MA; Valadares DG; França JR; Rodrigues LB; Duarte MC; Lage PS; Andrade PH; Lage DP; Arruda LV; Abánades DR; Costa LE; Martins VT; Tavares CA; Castilho RO; Coelho EA; Faraco AA
    Int J Nanomedicine; 2014; 9():877-90. PubMed ID: 24627630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage-fused epitopes from Leishmania infantum used as immunogenic vaccines confer partial protection against Leishmania amazonensis infection.
    Costa LE; Chávez-Fumagalli MA; Martins VT; Duarte MC; Lage DP; Lima MI; Pereira NC; Soto M; Tavares CA; Goulart LR; Coelho EA
    Parasitology; 2015 Sep; 142(10):1335-47. PubMed ID: 26099574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic
    Mendonça DVC; Tavares GSV; Lage DP; Soyer TG; Carvalho LM; Dias DS; Ribeiro PAF; Ottoni FM; Antinarelli LMR; Vale DL; Ludolf F; Duarte MC; Coimbra ES; Chávez-Fumagalli MA; Roatt BM; Menezes-Souza D; Barichello JM; Alves RJ; Coelho EAF
    Biomed Pharmacother; 2019 Jan; 109():779-787. PubMed ID: 30551531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.
    Pereira IAG; Mendonça DVC; Tavares GSV; Lage DP; Ramos FF; Oliveira-da-Silva JA; Antinarelli LMR; Machado AS; Carvalho LM; Carvalho AMRS; Salustiano IV; Reis TAR; Bandeira RS; Silva AM; Martins VT; Chávez-Fumagalli MA; Humbert MV; Roatt BM; Duarte MC; Menezes-Souza D; Coimbra ES; Leite JPV; Coelho EAF; Gonçalves DU
    Parasite Immunol; 2020 Dec; 42(12):e12784. PubMed ID: 32772379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis.
    Freitas CS; Oliveira-da-Silva JA; Lage DP; Costa RR; Mendonça DVC; Martins VT; Reis TAR; Antinarelli LMR; Machado AS; Tavares GSV; Ramos FF; Coelho VTS; Brito RCF; Ludolf F; Chávez-Fumagalli MA; Roatt BM; Ramos GS; Munkert J; Ottoni FM; Campana PRV; Humbert MV; Coimbra ES; Braga FC; Pádua RM; Coelho EAF
    Parasitol Res; 2021 Jan; 120(1):321-335. PubMed ID: 33191446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphotericin B resistance correlates with increased fitness
    Mano C; Kongkaew A; Tippawangkosol P; Somboon P; Roytrakul S; Pescher P; Späth GF; Uthaipibull C; Tantiworawit A; Siriyasatien P; Jariyapan N
    Front Microbiol; 2023; 14():1156061. PubMed ID: 37089544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy induced by the oral administration of Agaricus blazei Murill against Leishmania amazonensis.
    Valadares DG; Duarte MC; Ramírez L; Chávez-Fumagalli MA; Lage PS; Martins VT; Costa LE; Ribeiro TG; Régis WC; Soto M; Fernandes AP; Tavares CA; Coelho EA
    Parasitol Res; 2012 Oct; 111(4):1807-16. PubMed ID: 22797606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection.
    Tavares GSV; Mendonça DVC; Miyazaki CK; Lage DP; Soyer TG; Carvalho LM; Ottoni FM; Dias DS; Ribeiro PAF; Antinarelli LMR; Ludolf F; Duarte MC; Coimbra ES; Chávez-Fumagalli MA; Roatt BM; Menezes-Souza D; Barichello JM; Alves RJ; Coelho EAF
    Parasitol Int; 2019 Feb; 68(1):63-72. PubMed ID: 30339837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.